Tech Company Financing Transactions

Velocimed Funding Round

Velocimed, based in Maple Grove, secured $16.5 million from RiverVest Venture Partners, The Vertical Group and Warburg Pincus.

Transaction Overview

Company Name
Announced On
9/21/2004
Transaction Type
Venture Equity
Amount
$16,500,000
Round
Series D
Proceeds Purpose
The funds from this significant round of financing will be used to complete the pivotal U.S. clinical trial for the Proxis Embolic Protection System, and to launch the Premere PFO Closure System and Venture Wire Control Catheter internationally.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
11400 73rd Avenue 134
Maple Grove, MN 55369
USA
Email Address
Not Recorded
Overview
Velocimed is a developer, manufacturer and marketer of Medical Devices & Instruments whose products will be used in a broad range of interventional cardiology and neurology applications.
Profile
Velocimed LinkedIn Company Profile
Social Media
Velocimed Company Twitter Account
Company News
Velocimed News
Facebook
Velocimed on Facebook
YouTube
Velocimed on YouTube

Management Team

Title
Name
Email & Social
   LinkedIn Profile   Twitter Account   News   on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/21/2004: OZ Communications venture capital transaction
Next: 9/21/2004: Knowledge Management Solutions venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary